In July, the World Health Organization declared Monkeypox a global health emergency. New viruses are another reminder that healthcare systems and pharmacies must thermally protect a growing number of vaccines, biologics, and therapeutic drugs.
These pharmaceuticals are often stored over a broader range of temperatures for optimal efficacy. This potentially expands the breadth and expense of cold chain solutions needed on clinical sites.
Stirling Ultracold has the team and temperature within its cold chain services to bring biologic, cellular, and genetic therapeutics to patient points of care, providing white-glove service every step of the way.
The team also understands that high-value medicines ebb and flow and that its storage solution must offer stability, flexibility, or scalability to maintain efficacy effectively.
Stirling Ultracold’s clients receive breakthrough technology through its reliable, compact, and portable ultracold storage solutions for the patient.
